Investors lobby - Together Pharma

Skip to content

Investors

Investors Lobby
Company Profile
Company Presentation
Immediate Reports
Investors News
Financial Reports
From The Press
Media
Stock Chart
FAQ
Contact IR

Investors News

Together Pharma Reports Preliminary Q3 2024 Revenues of 23.4 Million Shekels, Totals 73.4 Million for First Nine Months

30/10/2024

Together Pharma with robust preliminary results for the first quarter of 2023: Quarterly revenues of approximately NIS 21 million, an increase of 700% compared to revenues of NIS 3 million in the corresponding quarter last year and compared to revenues of approximately NIS 31 million in all of 2022

18/04/2023

Together opens up a new European market: received a permit to import its products from Germany to England Together regularly imports a variety of strains from Uganda to an EU-GMP Cantourage facility in Germany, and has recently announced another shipment of some 800 kgs from Uganda to Germany

10/05/2022

From The Press

The Marker: Together’s share jumps on the stock exchange following expectations of a significant increase in revenue.

25/02/2025

Ice: Israeli cannabis giant breaks record: revenue soars to 50 million shekels

26/08/2024

Immediate Reports

Update Regarding the Medical Cannabis Unit’s Notice at the Ministry of Health

13/07/2026

Development of an inhaler for administering medical cannabis treatment in a measured dose

06/05/2026

stock

Tel Aviv: TGTR

2.26

Price

2.12%

Change percentage

4.70

Change

Day High: 229.40

Day Low: 224.90

Last Update:13:49 16/07/2026

Presentations

Investor Presentation – June 2026 (Hebrew Version)

Financial Reports

Annual Report 2025

26/03/2026

2nd Quarter 2025

28/08/2025

Mail Alert

Subscribe to Receive Notifications by Email

First Name

Last Name

Email